Regeneration is up-regulated in Glatiramer acetate treated dy2J/dy2J mice with congenital muscular dystrophy

被引：0
|
作者：
Dadush, O. [1 ]
Aga-Mizrachi, S. [1 ]
Ettinger, K. [1 ]
Tabakman, R. [1 ]
Elbaz, M. [1 ]
Fellig, J. [1 ]
Barak, V. [1 ]
Nevo, Y. [1 ]
机构：
[1] Hebrew Univ Jerusalem, Med Ctr, Jerusalem, Israel
来源：
NEUROMUSCULAR DISORDERS | 2009年 / 19卷 / 8-9期
关键词：
D O I：
10.1016/j.nmd.2009.06.237
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：619 / 619
页数：1
相关论文
共 50 条
  • [1] Improved muscle strength and mobility in the dy2J/dy2J mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate
    Dadush, Oshrat
    Aga-Mizrachi, Shlomit
    Ettinger, Keren
    Tabakman, Rinat
    Elbaz, Moran
    Fellig, Yakov
    Yanay, Nurit
    Nevo, Yoram
    NEUROMUSCULAR DISORDERS, 2010, 20 (04) : 267 - 272
  • [2] Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy2J/dy2J Mouse
    Elbaz, Moran
    Yanay, Nurit
    Aga-Mizrachi, Shlomit
    Brunschwig, Zivia
    Kassis, Ibaa
    Ettinger, Keren
    Barak, Vivian
    Nevo, Yoram
    ANNALS OF NEUROLOGY, 2012, 71 (05) : 699 - 708
  • [3] Glatiramer acetate improved motor conduction velocity in dy2J/dy2J mouse peripheral neuropathy
    Yanay, N.
    Nevo, Y.
    Felig, Y.
    Elbaz, M.
    Gelb, S.
    Mitrani-Rosenbaum, S.
    Rabie, M.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 783 - 783
  • [4] Antioxidants Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
    Harandi, Vahid M.
    Oliveira, Bernardo Moreira Soares
    Allamand, Valerie
    Friberg, Ariana
    Fontes-Oliveira, Cibely C.
    Durbeej, Madeleine
    ANTIOXIDANTS, 2020, 9 (03)
  • [5] Laminin α1 reduces muscular dystrophy in dy2J mice
    Gawlik, Kinga, I
    Harandi, Vahid M.
    Cheong, Rachel Y.
    Petersen, Asa
    Durbeej, Madeleine
    MATRIX BIOLOGY, 2018, 70 : 36 - 49
  • [6] Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
    Korner, Zandra
    Durbeej, Madeleine
    PLOS ONE, 2016, 11 (01):
  • [7] Losartan improves muscle strength and ameliorates fibrosis in the dy2J/dy2J mouse model of merosin deficient congenital muscular dystrophy
    Elbaz, M.
    Aga-Mizrachi, S.
    Yanay, N.
    Dadush, O.
    Ettinger, K.
    Brunschwig, Z.
    Rabie, M.
    Barak, V.
    Nevo, Y.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 656 - 656
  • [8] ULTRASTRUCTURAL ALTERATIONS OF MOTOR END PLATE IN MYOTONIC DYSTROPHY OF MOUSE (DY2J/DY2J)
    GILBERT, JJ
    STEINBERG, MC
    BANKER, BQ
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1973, 32 (03): : 345 - 364
  • [9] Muscular transverse relaxation time measurement by magnetic resonance imaging at 4 Tesla in normal and dystrophic dy/dy and dy2j/dy2j mice
    Tardif-de Géry, S
    Vilquin, JT
    Carlier, P
    Raynaud, JS
    Wary, C
    Schwartz, K
    Leroy-Willig, A
    NEUROMUSCULAR DISORDERS, 2000, 10 (07) : 507 - 513
  • [10] Losartan up-regulates NFκB signaling pathway and favors survival versus apoptosis in the dy2J/dy2J mouse model of Congenital Muscular Dystrophy
    Elbaz, M.
    Yanay, N.
    Gelb, S.
    Rabie, M.
    Rosenbaum, S. Mitrani
    Nevo, Y.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 782 - 782
12345